Skip to main content
. 2018 Jul;39(7):1286–1292. doi: 10.3174/ajnr.A5676

Table 1:

Clinical characteristics and imaging findings of patients with low- and high-grade stenotic basilar artery plaque

All (n = 126) Low-Grade Stenosis (<50%, n = 46) High-Grade Stenosis (≥50%, n = 80) P Value
Age (mean) (yr) 61.5 ± 10.0 63.70 ± 9.4 60.3 ± 10.1 .07
Sex (male) (No.) (%) 82 (65.1%) 33 (71.7%) 49 (61.3%) .23
Diabetes (No.) (%) 42 (33.3%) 15 (32.6%) 27 (33.8%) .90
Smoking (No.) (%) 35 (27.8%) 13 (28.3%) 22 (27.5%) .93
Hypertension (No.) (%) 101 (80.2%) 37 (80.4%) 64 (80.0%) .96
Hyperlipidemia (No.) (%) 65 (51.6%) 18 (39.1%) 47 (58.8%) .03a
Coronary artery disease (No.) (%) 5 (4.0%) 3 (6.5%) 2 (2.5%) .27
Preadmission aspirin use (No.) (%) 31 (24.6%) 9 (19.6%) 22 (27.5%) .32
Preadmission statin use (No.) (%) 17 (13.5%) 4 (8.7%) 13 (16.3%) .23
NIHSS score (median) (range) 1 (0–11) 2 (0–11) 0 (0–6) <.001a
Degree of stenosis (mean) (%) 52.6 ± 15.8 35.2 ± 9.7 62.6 ± 7.9 <.001a
Enhancement percentage (mean) 17.4 ± 28.4 21.1 ± 33.1 15.3 ± 25.3 .27
Intraplaque hemorrhage (No.) (%) 22 (17.5%) 9 (19.6%) 13 (16.3%) .63
Minimum lumen area (mean) (mm2) 3.2 ± 2.7 5.1 ± 3.4 2.1 ± 1.3 <.001a
Plaque burden (mean) (%) 84.0 ± 9.1 75.9 ± 8.2 88.6 ± 5.7 <.001a
Symptomatic (No.) (%) 66 (52.4%) 28 (60.9%) 38 (47.5%) .15
a

Statistically significant.